Article
If one were to ask Arthur Jordan, OD, whether an optical dispensary is a vital and necessary part of an ophthalmic practice, one would most likely hear him snicker in a way that connotes an 'are-you-kidding-me?' response.
4DMT releases positive topline interim data from Part 1 of the SPECTRA clinical trial
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
Ashvattha Therapeutics secures $50M in financing to advance clinical trials
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
Bausch + Lomb launches its enVista Aspire monofocal and toric IOLs in the European Union
Samsara Vision announces positive intermediate-term visual and safety outcomes of SING IMT 6 months post-surgery